Purity testing for GHK-Cu has to answer two separate questions that a plain peptide analysis does not: is the peptide sequence correct, and is the copper present in the right ratio and coordination state. An HPLC trace alone answers only the first.
Two things being measured, not one
A batch of GHK-Cu can be sequence-pure and still be a poor research reagent if the copper has partially dissociated or if excess free copper remains from synthesis. A complete characterization treats "purity" as covering both the organic peptide component and the inorganic copper component, rather than defaulting to a single HPLC percentage the way a simple linear peptide would.
Sequence purity and identity
Reverse-phase HPLC remains the primary method for quantifying peptide purity and detecting synthesis-related impurities — the general principles are covered in understanding HPLC purity. Mass spectrometry is run alongside it to confirm that the detected mass matches the expected mass of the intact copper complex, not just the bare tripeptide.
Copper content and coordination state
Because the copper is functionally part of the molecule, its content is checked separately, typically through elemental or spectroscopic analysis confirming a defined copper-to-peptide ratio. UV-visible spectroscopy is also informative here: an intact Cu(II)-GHK complex has a characteristic absorbance signature that shifts if the copper has been lost or reduced, giving analysts a fast way to flag a compromised sample before it reaches a full battery of testing.
Stability and repeat testing
Because the copper coordination can degrade under heat, light, or improper reconstitution even when the original synthesis was flawless, some labs re-verify a sample after storage or after reconstitution rather than relying solely on the original batch data. A common failure mode is partial copper dissociation without a corresponding drop in peptide-sequence purity — a scenario that a sequence-only HPLC test would miss entirely but that copper-ratio analysis or UV-visible spectroscopy would flag. This is one of the more concrete reasons GHK-Cu testing protocols differ from those used for simple linear peptides.
Reading the finished documentation
All of this — sequence purity, mass confirmation, and copper-ratio data — should appear together on a batch-specific certificate of analysis, ideally backed by independent third-party testing rather than internal claims alone. A researcher evaluating a GHK-Cu vial is really evaluating whether that paperwork actually matches the vial in hand, not just whether paperwork exists at all.
Taken together, these layers of testing are what allow two independent labs working from the same nominal product to actually compare notes — without them, "GHK-Cu" is a name on a label rather than a chemically defined reagent.
Product page: GHK-Cu research vials.
Research Use Only. Supplied strictly for laboratory research and development — not for human or veterinary use, consumption, or any therapeutic or diagnostic purpose. This article is research education, not usage guidance.